ADVA
13.7.2021 09:02:08 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced the Cyprus Telecommunications Authority (Cyta) is leveraging its timing technology in a national synchronization network, addressing legacy timing applications and ensuring a smooth migration to precise packet timing for 5G critical services in the future. The solution enables Cyta to meet the stringent timing requirements of next-generation services while supporting all existing mobile technologies. ADVA’s Oscilloquartz PTP grandmaster clock and GNSS receiver technology not only enhances synchronization precision but also provides new levels of resilience and reliability. The project was facilitated by ADVA’s partners, the ICT solutions providers GCC Computers Ltd and ADAPTIT S.A., which will also provide ongoing technical support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005088/en/
“Cyta now has a synchronization network able to address the accuracy, efficiency and stability demands of 5G. With support for NTP, PTP and SyncE, our technology ensures that the new infrastructure meets the needs of Cyta’s legacy applications, ensuring a smooth migration to the precise packet timing that is critical for 5G services,” said Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Together with GCC’s and ADAPTIT S.A.’s teams, we’ve engineered a solution that fits Cyta’s exact requirements. It provides the sub-microsecond accuracy necessary for advanced mobile applications together with hardware redundancy for unbeatable resilience. What’s more, our Ensemble Controller network management technology makes it simple to operate.”
Prior to the deployment, Cyta’s timing network was based purely on frequency synchronization. It now distributes stable and accurate phase and time-of-day information, supporting the enhanced spectrum utilization needed for 5G. The solution features the OSA 5420 Series of grandmaster clocks, optimized for mobile backhaul and fronthaul in the radio access network. In the core, the OSA 5440 provides highest accuracy and availability with its dual multi-band, multi-constellation GNSS receiver and full hardware redundancy. The technology is remotely controlled by ADVA’s Ensemble Sync Director. This provides a powerful management platform, giving Cyta full visibility of its synchronization infrastructure and assuring perfect end-to-end timing.
“We’ve worked closely with Cyta to create a synchronization solution that fits its precise needs. Able to support both legacy and next-generation packet networking, Cyta’s new timing network is space- and power-efficient, assured by in-service PTP and GNSS monitoring and protected by hardware redundancy. Our engineers have also provided support at every stage of the process and made certain that the installation was carried out without any disruption to services,” commented Vasileios Karavasilis, commercial director, ADAPTIT S.A. “As a key distributor of ADVA’s Oscilloquartz solutions, we know all about the value of precise and reliable timing in mission-critical networks. Cyta is now prepared for mass 5G rollout with a synchronization architecture able to meet key challenges both now and in the future.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com .
About GCC Computers Ltd.
GCC Computers has a distinguished market presence in Cyprus as an ICT System Integrator and has built a strong reputation as the employer of the best technology professionals. For more than 30 years, GCC has been acknowledged with considerable success serving Public/Government, Telecommunications & Utilities, Banking/Finance and SME (Small-Medium-Enterprise) sectors with innovative solutions. GCC’s expertise and extensive partnerships help clients harness the technology power to thrive on change and guide their digital transformation journeys. For more information, please visit us at www.gcc.com.cy .
About ADAPTIT S.A.
ADAPTIT S.A. is a highly specialized System Integrator that combines latest technology trends to offer its clients innovative tailor-made solutions, according to their needs, and finally delivers high-quality TURNKEY PROJECTS, ensuring the highest possible performance of their investment. With a wide-range portfolio of networking solutions ADAPTIT provides networking expertise to Service Providers, Government Agencies and Enterprises. ADAPTIT S.A. has presence in most European countries, having delivered similar major projects to several Service Providers in Spain, Sweden, Finland, Portugal, Poland, Romania, Malta, Bulgaria, and Albania. For more information, please visit us at www.adaptit.gr .
About Cyta
Cyta is the leading provider of integrated electronic communications in Cyprus. Making the most of its technologically advanced networks, it offers a wide range of services and solutions to meet the ever-increasing demands of its residential and business customers for voice, data and content applications. With a pivotal role in the digital transformation of Cyprus, Cyta is deploying an island-wide, fiber-optic network, while it progressively upgrades its mobile network technology. It advances and maintains subsea and satellite networks for international connections of strategic importance that have established Cyprus as a regional telecommunications and connectivity hub in the Eastern Mediterranean. www.cyta.com.cy
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005088/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HTEC Research: Only One in Three Healthcare Organizations is Ready to Scale AI28.4.2026 15:22:00 CEST | Press release
Healthcare and life sciences leaders are advancing AI with caution—fragmentation, capability gaps, and execution challenges are slowing enterprise-wide impact AI is already embedded across healthcare and life sciences. Most organizations are deploying it, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428872907/en/ HTEC, a global AI‑first provider of software and hardware design and engineering services, today released new research based on a global survey of 253 C-level HLS executives across the United States, United Kingdom, Germany, Spain, Saudi Arabia, and the UAE. AI is already embedded across healthcare and life sciences. Most organizations are deploying AI, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. HTEC, a global AI‑first provider of software and hardware design a
JPMorganChase Named First-Ever Global Banking Partner of the Olympic Games28.4.2026 15:00:00 CEST | Press release
International Olympic Committee and JPMorganChase Announce Landmark Global Olympic Partnership The International Olympic Committee (IOC) and JPMorganChase today announced a landmark Worldwide Olympic Partnership, making JPMorganChase the first Global Banking Partner in Olympic history. The partnership includes the Los Angeles 2028 Olympic and Paralympic Games (LA28 Games) and the French Alps 2030 Olympic and Paralympic Winter Games. The firm has also reached an agreement with LA28 to become the Official Bank of Team USA and LA28, and a Founding Partner of the LA28 Games. The partnership reflects a shared commitment to ambition and excellence, and places athletes and communities at its core. Kirsty Coventry, President of the IOC, commented: “JPMorganChase is the first Global Partner from the banking sector in Olympic history, and we are proud to welcome them to the Worldwide Olympic Partner programme. This partnership reflects our shared values of ambition, excellence and will support t
BlueSnap, Powered by Payroc, Launches Local Acquiring in New Zealand to Boost Approval Rates and Reduce Cross-Border Costs28.4.2026 15:00:00 CEST | Press release
BlueSnap, powered by Payroc, today announced the availability of local acquiring in New Zealand, expanding its global payment orchestration capabilities and enabling businesses to process transactions domestically. Local acquiring allows businesses with a legal entity in New Zealand to process payments through domestic acquiring banks rather than routing transactions cross-border. This helps increase authorization rates, reduce payment failures, and lower transaction costs, critical factors for businesses selling into the region. Why Local Acquiring in New Zealand Matters For B2B and B2C businesses operating globally, cross-border payments often lead to higher fees and lower approval rates. Building local acquiring infrastructure independently requires managing multiple bank relationships, compliance, and integrations, making it costly and complex. BlueSnap simplifies this by providing local acquiring through a single platform, allowing businesses with a legal entity in New Zealand to
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder28.4.2026 14:42:00 CEST | Press release
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145279/en/ Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right) Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, frequency, and incontinence. While intravesical botulinum toxin injection is an established second-line treatment, the invasive procedure limits patient access and acceptance. The ViXe program is desi
Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care28.4.2026 14:28:00 CEST | Press release
CTIBIOTECH™, a leading innovator in advanced human tissue engineering, proudly announces CTIONCOTEST™ platform is awarded Major Bpifrance Funding to Industrialize 3D Bioprinted Cancer Models CTIBIOTECH Announces the CTIONCOTEST ™ Project to Revolutionize Cancer Research with 3D Bioprinted Microtumors, Backed by France 2030 and Bpifrance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428242352/en/ The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the pla
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom